How does a patient maximally benefit from anti-infective chemotherapy?
Drusano
G L
GL
D000935:Antifungal Agents / Q000009:adverse effects* / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use*; D003577:Cytochrome P-450 Enzyme System / Q000235:genetics / Q000378:metabolism; D006801:Humans; D011743:Pyrimidines / Q000009:adverse effects* / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use*; D014230:Triazoles / Q000009:adverse effects* / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use*; D065819:Voriconazole
D000935:Antifungal Agents; D011743:Pyrimidines; D014230:Triazoles; D003577:Cytochrome P-450 Enzyme System; D065819:Voriconazole